Cargando…

Prognostic and predictive role of a metabolic rate‐limiting enzyme signature in hepatocellular carcinoma

OBJECTIVES: Abnormal expression of metabolic rate‐limiting enzymes drives the occurrence and progression of hepatocellular carcinoma (HCC). This study aimed to elucidate the comprehensive model of metabolic rate‐limiting enzymes associated with the prognosis of HCC. MATERIALS AND METHODS: HCC animal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhangding, Fu, Yao, Xia, Anliang, Chen, Chen, Qu, Jiamu, Xu, Guifang, Zou, Xiaoping, Wang, Qiang, Wang, Shouyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488553/ https://www.ncbi.nlm.nih.gov/pubmed/34423480 http://dx.doi.org/10.1111/cpr.13117

Ejemplares similares

APAF1‐Binding Long Noncoding RNA Promotes Tumor Growth and Multidrug Resistance in Gastric Cancer by Blocking Apoptosome Assembly
por: Wang, Qiang, et al.
Publicado: (2022)

m(6)A Reader HNRNPA2B1 Promotes Esophageal Cancer Progression via Up-Regulation of ACLY and ACC1
por: Guo, Huimin, et al.
Publicado: (2020)

The cancer-testis lncRNA LINC01977 promotes HCC progression by interacting with RBM39 to prevent Notch2 ubiquitination
por: Xia, Anliang, et al.
Publicado: (2023)

SOAT1 Promotes Gastric Cancer Lymph Node Metastasis Through Lipid Synthesis
por: Zhu, Tingting, et al.
Publicado: (2021)

Emerging role of RNA methyltransferase METTL3 in gastrointestinal cancer
por: Wang, Qiang, et al.
Publicado: (2020)

A pan-cancer analysis of the prognostic and immunological roles of matrix metalloprotease-1 (MMP1) in human tumors
por: Mao, Shuai, et al.
Publicado: (2023)

Stabilization of IGF2BP1 by USP10 promotes breast cancer metastasis via CPT1A in an m6A-dependent manner
por: Shi, Jiajun, et al.
Publicado: (2023)

Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis
por: Yeh, Hsi-Wen, et al.
Publicado: (2017)

Profiles of prognostic alternative splicing signature in hepatocellular carcinoma
por: Wu, Fangming, et al.
Publicado: (2020)

Prognostic signatures of sphingolipids: Understanding the immune landscape and predictive role in immunotherapy response and outcomes of hepatocellular carcinoma
por: Zhang, Xin, et al.
Publicado: (2023)

Establishment and validation of a cholesterol metabolism-related prognostic signature for hepatocellular carcinoma
por: Tang, Linsong, et al.
Publicado: (2022)

A Prognostic Gene Signature for Hepatocellular Carcinoma
por: Chen, Rong, et al.
Publicado: (2022)

The prognostic value of an autophagy-related lncRNA signature in hepatocellular carcinoma
por: Yang, Shiming, et al.
Publicado: (2021)

An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma
por: Chen, Xilang, et al.
Publicado: (2023)

HVPG signature: A prognostic and predictive tool in hepatocellular carcinoma
por: Qi, Xiaolong, et al.
Publicado: (2016)

Identification of prognostic long non-coding RNA signature with potential drugs in hepatocellular carcinoma
por: Hao, Fengjie, et al.
Publicado: (2021)

Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020)

A New Clinical Nomogram From the TCGA Database to Predict the Prognosis of Hepatocellular Carcinoma
por: Ye, Dingde, et al.
Publicado: (2021)

Identification of immune landscape signatures associated with clinical and prognostic features of hepatocellular carcinoma
por: Yan, Hongmei, et al.
Publicado: (2020)

Autophagy-Related Signatures as Prognostic Indicators for Hepatocellular Carcinoma
por: Ye, Wen, et al.
Publicado: (2022)

Identification and Validation of an Immune-related Prognostic Signature for Hepatocellular Carcinoma
por: Xia, Xinxin, et al.
Publicado: (2021)

Immunohistochemical Signature Add Prognostic Value in Patients With Early and Intermediate Hepatocellular Carcinoma Underwent Curative Liver Resection
por: Bai, Yannan, et al.
Publicado: (2021)

A Novel Four-Gene Signature as a Potential Prognostic Biomarker for Hepatocellular Carcinoma
por: Wang, Guangfeng, et al.
Publicado: (2021)

A bile acid-related prognostic signature in hepatocellular carcinoma
por: Zhang, Wang, et al.
Publicado: (2022)

Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma
por: Weng, Jialei, et al.
Publicado: (2021)

A Novel RNA Binding Protein-Related Prognostic Signature for Hepatocellular Carcinoma
por: Huang, Yongbiao, et al.
Publicado: (2020)

Prognostic Implication of a Cuproptosis-Related miRNA Signature in Hepatocellular Carcinoma
por: Jin, Ze, et al.
Publicado: (2022)

A Nucleotide Metabolism-Related Gene Signature for Risk Stratification and Prognosis Prediction in Hepatocellular Carcinoma Based on an Integrated Transcriptomics and Metabolomics Approach
por: Wei, Tianfu, et al.
Publicado: (2023)

Silencing of circRACGAP1 sensitizes gastric cancer cells to apatinib via modulating autophagy by targeting miR-3657 and ATG7
por: Ma, Ling, et al.
Publicado: (2020)

The mRNA Expression Signature and Prognostic Analysis of Multiple Fatty Acid Metabolic Enzymes in Clear Cell Renal Cell Carcinoma
por: Zhao, Zuohui, et al.
Publicado: (2019)

Retinoic Acid Metabolism-Related Enzyme Signature Identified Prognostic and Immune Characteristics in Sarcoma
por: Xu, HuaiYuan, et al.
Publicado: (2022)

A Novel Prognostic Signature Associated with Immunotherapeutic Response for Hepatocellular Carcinoma
por: Jin, Xinmin, et al.
Publicado: (2022)

Genomic Instability of Mutation-Derived Gene Prognostic Signatures for Hepatocellular Carcinoma
por: Song, Ze-Bing, et al.
Publicado: (2021)

A prognostic signature of cuproptosis and TCA-related genes for hepatocellular carcinoma
por: Zhang, Qi, et al.
Publicado: (2022)

Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma
por: Chen, Yuqiao, et al.
Publicado: (2023)

Immunological significance of prognostic alternative splicing signature in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Systematic Characterization of Novel Immune Gene Signatures Predicts Prognostic Factors in Hepatocellular Carcinoma
por: Xu, Dafeng, et al.
Publicado: (2021)

Gene Signatures and Prognostic Values of m6A Regulators in Hepatocellular Carcinoma
por: Wang, Pei, et al.
Publicado: (2020)

Prognostic Biomarker Identification Through Integrating the Gene Signatures of Hepatocellular Carcinoma Properties
por: Cai, Jialin, et al.
Publicado: (2017)

A novel ferroptosis phenotype‐related clinical‐molecular prognostic signature for hepatocellular carcinoma
por: Deng, Tuo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1rfc7ljecr9e6vvm7ja4d144t0